The evaluation of enhanced feedback interventions to reduce unnecessary blood transfusions (AFFINITIE): protocol for two linked cluster randomised factorial controlled trials.

Autor: Hartley S; Clinical Trials Research Unit, University of Leeds, Leeds, UK. s.hartley@leeds.ac.uk., Foy R; Leeds Institute of Health Sciences, University of Leeds, Leeds, UK., Walwyn REA; Clinical Trials Research Unit, University of Leeds, Leeds, UK., Cicero R; Clinical Trials Research Unit, University of Leeds, Leeds, UK., Farrin AJ; Clinical Trials Research Unit, University of Leeds, Leeds, UK., Francis JJ; Centre for Health Services Research, University of London, London, UK., Lorencatto F; Centre for Health Services Research, University of London, London, UK., Gould NJ; Centre for Health Services Research, University of London, London, UK., Grant-Casey J; NHS Blood & Transplant, Oxford, UK., Grimshaw JM; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.; Department of Medicine, University of Ottawa, Ottawa, Canada., Glidewell L; Leeds Institute of Health Sciences, University of Leeds, Leeds, UK., Michie S; Centre for Outcomes Research and Effectiveness, University College London, London, UK., Morris S; Department of Applied Health Research, University College London, London, UK., Stanworth SJ; Transfusion Medicine, NHS Blood and Transplant, Oxford, UK.; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Radcliffe Department of Medicine, University of Oxford, and Oxford BRC Haematology Theme, Oxford, UK.
Jazyk: angličtina
Zdroj: Implementation science : IS [Implement Sci] 2017 Jul 03; Vol. 12 (1), pp. 84. Date of Electronic Publication: 2017 Jul 03.
DOI: 10.1186/s13012-017-0614-8
Abstrakt: Background: Blood for transfusion is a frequently used clinical intervention, and is also a costly and limited resource with risks. Many transfusions are given to stable and non-bleeding patients despite no clear evidence of benefit from clinical studies. Audit and feedback (A&F) is widely used to improve the quality of healthcare, including appropriate use of blood. However, its effects are often inconsistent, indicating the need for coordinated research including more head-to-head trials comparing different ways of delivering feedback. A programmatic series of research projects, termed the 'Audit and Feedback INterventions to Increase evidence-based Transfusion practIcE' (AFFINITIE) programme, aims to test different ways of developing and delivering feedback within an existing national audit structure.
Methods: The evaluation will comprise two linked 2×2 factorial, cross-sectional cluster-randomised controlled trials. Each trial will estimate the effects of two feedback interventions, 'enhanced content' and 'enhanced follow-on support', designed in earlier stages of the AFFINITIE programme, compared to current practice. The interventions will be embedded within two rounds of the UK National Comparative Audit of Blood Transfusion (NCABT) focusing on patient blood management in surgery and use of blood transfusions in patients with haematological malignancies. The unit of randomisation will be National Health Service (NHS) trust or health board. Clusters providing care relevant to the audit topics will be randomised following each baseline audit (separately for each trial), with stratification for size (volume of blood transfusions) and region (Regional Transfusion Committee). The primary outcome for each topic will be the proportion of patients receiving a transfusion coded as unnecessary. For each audit topic a linked, mixed-method fidelity assessment and cost-effectiveness analysis will be conducted in parallel to the trial.
Discussion: AFFINITIE involves a series of studies to explore how A&F may be refined to change practice including two cluster randomised trials linked to national audits of transfusion practice. The methodology represents a step-wise increment in study design to more fully evaluate the effects of two enhanced feedback interventions on patient- and trust-level clinical, cost, safety and process outcomes.
Trial Registration: http://www.isrctn.com/ISRCTN15490813.
Databáze: MEDLINE
Externí odkaz: